Today's Daily Dose brings you news about second quarter financial results of GenMark, Illumina and Tandem; anticipated milestones of Lexicon Pharma; Nektar's regulatory catalyst and FDA approval of Progenics' radioactive therapeutic Azedra, among others.
from RTT - Biotech https://ift.tt/2M1aLPo
via IFTTT
No comments:
Post a Comment